84-5672-05 [取扱停止]SARS-CoV-2 Nucleoprotein 100ug 378024

※お見積書はカートで印刷できます

冷凍 保管・搬送時に冷凍が必要な商品です。

特徴

  • Severe acute respiratory syndrome (SARS) is a lower respiratory tract illness that was first reported in patients from the Guandong Province of China in November 2002.
  • The causative agent, which was previously unknown, was isolated in 2003 and named as SARS coronavirus (SARS-CoV).
  • The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the coronavirus induced disease 19 (COVID-19) which emerged in China in late 2019, resulting in a worldwide epidemic (Zhou et al., 2020).
  • Human coronaviruses are the major cause of upper respiratory tract illness.
  • They are positive-stranded RNA viruses, and contain the largest viral RNA genomes known to date (27-31 kb).
  • SARS (severe acute respiratory syndrome) and COVID-19 are both caused by human coronaviruses, SARS-CoV and SARS-CoV-2, respectively.
  • The genome of SARS-CoV-2 shares 82% nucleotide identity with human SARS-CoV and 89% with bat SARS-like-CoVZXC21 (Lu et al., 2020; Zhao et al., 2020).
  • However, initially it displayed lower pathogenicity and higher human to human transmissibility (Li et al., 2020).
  • The coronavirus genome encodes four structural proteins: the spike (S) protein, nucleocapsid (N) protein, membrane (M) protein, and the envelope (E) protein.
  • The coronavirus nucleocapsid phosphoprotein (N, or nucleoprotein) is highly basic and binds the viral RNA as a dimeric entity into nucleocapsids which protect the viral genome, while also providing access for replication when required.
  • The nucleoprotein packages the positive strand viral genome RNA into a helical ribonucleocapsid (RNP) and plays a fundamental role during virion assembly through its interactions with the viral genome and membrane protein M.
  • It plays an important role in enhancing the efficiency of subgenomic viral RNA transcription as well as viral replication (Fan et al., 2005).
  • Applications:Suitable for use in ELISA and Western Blot.
  • Other applications not tested.
  • Recommended Dilution:ELISA: 0.01-1ug/mlOptimal dilutions to be determined by the researcher.
  • Storage and Stability:May be stored at 4°C for short-term only.
  • Aliquot to avoid repeated freezing and thawing.
  • Store at -20°C.
  • Aliquots are stable for 12 months after receipt.
  • For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

仕様

  • Size:100ug
  • Host:rabbit
  • Grade:Affinity Purified
  • Purity:Purified by Protein A affinity chromatography from serum.
  • Form:Supplied as a liquid in PBS, 0.09% sodium azide.
  • Specificity:Recognizes SARS-CoV-2 nucleoprotein.
  • Isotype:IgG
  • Calc Applications Abbrev:E WB
  • Immunogen:Recombinant full length protein corresponding to aa1-419 from SARS-CoV-2 nucleoprotein, fused to 6X His-Tag at C-terminal, expressed in E. coli.
  • Shelf Life:1year
  • EU Commodity Code:30021010
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
84-5672-05
型番
378024
入り数
1個
標準価格
206,000円(税抜)
WEB価格
取扱停止
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る